SKI II

CAS No. 312636-16-1

SKI II ( SKI-II; SKI II. Sphingosine kinase inhibitor II )

Catalog No. M18409 CAS No. 312636-16-1

SKI II is a highly selective and non-ATP-competitive S1P receptor inhibitor (IC50: 0.5 μM) while exhibiting no inhibitory action on other kinases including PKCα, PI3K, and ERK2.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 In Stock
10MG 51 In Stock
25MG 97 In Stock
50MG 168 In Stock
100MG 294 In Stock
200MG 530 In Stock
500MG 849 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SKI II
  • Note
    Research use only, not for human use.
  • Brief Description
    SKI II is a highly selective and non-ATP-competitive S1P receptor inhibitor (IC50: 0.5 μM) while exhibiting no inhibitory action on other kinases including PKCα, PI3K, and ERK2.
  • Description
    SKI-II is a selective non-lipid inhibitor of sphingosine kinase (IC50 = 0.5 μM). nhibits acute myelogenous leukemia cell growth in vitro and in vivo. SKI-II was more efficient than two known SphK1 inhibitors SK1-I and FTY720 in inhibiting AML cells. Meanwhile, it induced dramatic apoptosis in above AML cells, and the cytotoxicity by SKI-II was almost reversed by the general caspase inhibitor z-VAD-fmk. SKI-II treatment inhibited SphK1 activation, and concomitantly increased level of sphingosine-1-phosphate (S1P) precursor ceramide in AML cells.
  • Synonyms
    SKI-II; SKI II. Sphingosine kinase inhibitor II
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    SphK1
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    312636-16-1
  • Formula Weight
    302.78
  • Molecular Formula
    C15H11ClN2OS
  • Purity
    98%
  • Solubility
    DMSO : ≥ 100 mg/mL; 330.27 mM
  • SMILES
    c1cc(ccc1c1csc(n1)Nc1ccc(cc1)O)Cl
  • Chemical Name
    4-[[4-(4-Chlorophenyl)-2-thiazolyl]amino]phenol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. French KJ, et al. Y Res, 2003, 63(18), 5962-5969.
molnova catalog
related products
  • Yinxiancaoside C

    Yinxiancaoside C has antitumor effect.

  • Ligustroflavone

    Ligustroflavone has anti-inflammatory activity.

  • DTP3

    DTP3 is a selective MKK7/GADD45β inhibitor, which inhibits cancer-selective NF-κB survival pathway.